These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8396193)

  • 1. Passive immune protection by herpes simplex virus-specific monoclonal antibodies with different plaque development inhibition activity.
    Mannini-Palenzona A; Costanzo F; Cassai E; Campana G
    New Microbiol; 1993 Jul; 16(3):205-13. PubMed ID: 8396193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
    Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV.
    Sanna PP; De Logu A; Williamson RA; Hom YL; Straus SE; Bloom FE; Burton DR
    Virology; 1996 Jan; 215(1):101-6. PubMed ID: 8553581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibodies which recognize herpes simplex virus and their possible diagnostic application].
    Pupo Antúnez M; Hermida Díaz C; Morier Díaz L; García Infante S; Resik Aguirre S
    Rev Cubana Med Trop; 1997; 49(3):181-5. PubMed ID: 9685985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL; Duncan BE; Raybould TJ; Watson DH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of herpes simplex virus type 1 (HSV-1) plaque enlargement by neutralizing sera.
    Mannini-Palenzona A; Costanzo F; Foà-Tomasi L; Negosanti M; Lanzoni A
    Microbiologica; 1989 Jul; 12(3):231-40. PubMed ID: 2476650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-type dependent sensitivity of herpes simplex virus 1 mutants to plaque development inhibition by an anti-gD monoclonal antibody.
    Mannini-Palenzona A; Moschella A; Costanzo F; Manservigi R; Monini P
    New Microbiol; 1995 Oct; 18(4):351-8. PubMed ID: 8590387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-common and type-specific monoclonal antibodies to herpes simplex virus types 1 and 2.
    Bystrická M; Vancíková M; Kasalová M; Rajcáni J; Kostál M; Murányiová M; Poláková K; Russ G
    Acta Virol; 1991 Apr; 35(2):152-64. PubMed ID: 1681713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.
    Hemady R; Tauber J; Ihley TM; Opremcak EM; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2335-41. PubMed ID: 2173686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.
    Forrester AJ; Sullivan V; Simmons A; Blacklaws BA; Smith GL; Nash AA; Minson AC
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():369-75. PubMed ID: 1704412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of mice against experimental Japanese encephalitis virus infections by neutralizing anti-glycoprotein E monoclonal antibodies.
    Gupta AK; Lad VJ; Koshy AA
    Acta Virol; 2003; 47(3):141-5. PubMed ID: 14658841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies.
    Mester JC; Glorioso JC; Rouse BT
    J Infect Dis; 1991 Feb; 163(2):263-9. PubMed ID: 1846388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
    Nash AA; Ashford NP
    Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different mechanisms of protection by monoclonal and polyclonal antibodies during the course of herpes simplex virus infection.
    Eis-Hübinger AM; Mohr K; Schneweis KE
    Intervirology; 1991; 32(6):351-60. PubMed ID: 1657825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
    Kutinová L; Vonka V; Slichtová V
    Acta Virol; 1980 Dec; 24(6):391-8. PubMed ID: 6111199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A detergent-soluble extract of virus-infected cells free from infectious virus protects mice from lethal herpes simplex virus infection.
    Ohashi Y; Sakaue Y; Kato S; Wada T; Sato K
    Biken J; 1980 Dec; 23(4):199-204. PubMed ID: 6266395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.